NR2E1 | Nuclear receptor subfamily 2, group E, member 1 | Nuclear receptors Transcription factors
| | | | | Tissue enriched |
HTR5A | 5-hydroxytryptamine (serotonin) receptor 5A, G protein-coupled | G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
OLIG1 | Oligodendrocyte transcription factor 1 | Transcription factors
| | | | | Tissue enriched |
PSD2 | Pleckstrin and Sec7 domain containing 2 | | | | | | Tissue enriched |
SLITRK1 | SLIT and NTRK-like family, member 1 | Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
GABRA5 | Gamma-aminobutyric acid (GABA) A receptor, alpha 5 | FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
GRIN1 | Glutamate receptor, ionotropic, N-methyl D-aspartate 1 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins Transporters
| | | | | Tissue enriched |
KCNF1 | Potassium voltage-gated channel, subfamily F, member 1 | Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enriched |
MEPE | Matrix extracellular phosphoglycoprotein | Predicted secreted proteins
| | | | | Tissue enriched |
GAP43 | Growth associated protein 43 | Plasma proteins Transporters
| | | | | Tissue enriched |
GPM6B | Glycoprotein M6B | Predicted membrane proteins
| | | | | Tissue enriched |
KCNJ4 | Potassium inwardly-rectifying channel, subfamily J, member 4 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Group enriched |
KCNV1 | Potassium channel, subfamily V, member 1 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
TNR | Tenascin R | Predicted secreted proteins
| | | | | Tissue enriched |
C1orf61 | Chromosome 1 open reading frame 61 | | | | | | Tissue enriched |
ZIC5 | Zic family member 5 | Transcription factors
| | | | | Group enriched |
FXYD7 | FXYD domain containing ion transport regulator 7 | Predicted membrane proteins
| | | | | Tissue enriched |
GPM6A | Glycoprotein M6A | Predicted membrane proteins
| | | | | Tissue enriched |
KIAA1045 | KIAA1045 | | | | | | Group enriched |
CACNG3 | Calcium channel, voltage-dependent, gamma subunit 3 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
NKX6-2 | NK6 homeobox 2 | Transcription factors
| | | | | Group enriched |
TUBB4A | Tubulin, beta 4A class IVa | Disease related genes Plasma proteins
| | | | | Group enriched |
ATP6V1G2 | ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2 | | | | | | Tissue enriched |
SYN1 | Synapsin I | Disease related genes Plasma proteins
| | | | | Tissue enriched |
VWC2L | Von Willebrand factor C domain containing protein 2-like | Predicted secreted proteins
| | | | | Tissue enriched |
HPCA | Hippocalcin | Plasma proteins
| | | | | Tissue enriched |
HTR2C | 5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
KCNA1 | Potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia) | Disease related genes FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
MLC1 | Megalencephalic leukoencephalopathy with subcortical cysts 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC1A6 | Solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6 | Predicted membrane proteins Transporters
| | | | | Group enriched |
C11orf87 | Chromosome 11 open reading frame 87 | Predicted membrane proteins
| | | | | Tissue enriched |
EGR4 | Early growth response 4 | Transcription factors
| | | | | Group enriched |
FNDC9 | Fibronectin type III domain containing 9 | Predicted membrane proteins
| | | | | Group enriched |
KIF5A | Kinesin family member 5A | Disease related genes
| | | | | Tissue enriched |
MOBP | Myelin-associated oligodendrocyte basic protein | | | | | | Tissue enriched |
NTSR2 | Neurotensin receptor 2 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
PACSIN1 | Protein kinase C and casein kinase substrate in neurons 1 | Plasma proteins
| | | | | Tissue enriched |
SEPT3 | Septin 3 | | | | | | Tissue enriched |
TRIM67 | Tripartite motif containing 67 | Cytoskeleton related proteins
| | | | | Tissue enriched |
FOXG1 | Forkhead box G1 | Disease related genes Transcription factors
| | | | | Group enriched |
GPR26 | G protein-coupled receptor 26 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
LRRTM4 | Leucine rich repeat transmembrane neuronal 4 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
NPTX1 | Neuronal pentraxin I | Predicted secreted proteins
| | | | | Tissue enriched |
PNMA5 | Paraneoplastic Ma antigen family member 5 | | | | | | Group enriched |
FAM19A1 | Family with sequence similarity 19 (chemokine (C-C motif)-like), member A1 | Predicted secreted proteins
| | | | | Tissue enriched |
NKAIN2 | Na+/K+ transporting ATPase interacting 2 | Disease related genes Predicted membrane proteins
| | | | | Tissue enriched |
NSG2 | Neuron-specific protein family member 2 | Predicted membrane proteins
| | | | | Group enriched |
RTN1 | Reticulon 1 | Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
SLC17A6 | Solute carrier family 17 (vesicular glutamate transporter), member 6 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SNAP25 | Synaptosomal-associated protein, 25kDa | FDA approved drug targets Transporters
| | | | | Tissue enriched |